| [1] |
|
| [2] |
FUJIO A, KAWAGISHI N, ECHIZENYA T, et al. Long-term survival with growth hormone replacement after liver transplantation of pediatric nonalcoholic steatohepatitis complicating acquired hypopituitarism[J]. Tohoku J Exp Med, 2015, 235(1): 61-67. DOI: 10.1620/tjem.235.61. |
| [3] |
KANG SJ, KWON A, JUNG MK, et al. High prevalence of nonalcoholic fatty liver disease among adolescents and young adults with hypopituitarism due to growth hormone deficiency[J]. Endocr Pract, 2021, 27(11): 1149-1155. DOI: 10.1016/j.eprac.2021.06.003. |
| [4] |
YUAN XX, ZHU HJ, PAN H, et al. Clinical characteristics of non-alcoholic fatty liver disease in Chinese adult hypopituitary patients[J]. World J Gastroenterol, 2019, 25(14): 1741-1752. DOI: 10.3748/wjg.v25.i14.1741. |
| [5] |
STEFAN N, HÄRING HU, CUSI K. Non-alcoholic fatty liver disease: causes, diagnosis, cardiometabolic consequences, and treatment strategies[J]. Lancet Diabetes Endocrinol, 2019, 7(4): 313-324. DOI: 10.1016/S2213-8587(18)30154-2. |
| [6] |
KROWKA MJ, FALLON MB, KAWUT SM, et al. International liver transplant society practice guidelines: diagnosis and management of hepatopulmonary syndrome and portopulmonary hypertension[J]. Transplantation, 2016, 100(7): 1440-1452. DOI: 10.1097/TP.0000000000001229. |
| [7] |
CEZA MR, GARCIA E, ANSELMI CE, et al. Prevalence and characteristics of hepatopulmonary syndrome in children with cirrhosis in southern Brazil[J]. Eur J Gastroenterol Hepatol, 2019, 31(1): 10-15. DOI: 10.1097/MEG.0000000000001207. |
| [8] |
TORⅡ N, ICHIHARA A, MIZUGUCHI Y, et al. Hormone-replacement therapy for hepatopulmonary syndrome and NASH associated with hypopituitarism[J]. Intern Med, 2018, 57(12): 1741-1745. DOI: 10.2169/internalmedicine.0027-17. |
| [9] |
JUNG D, SEO GH, KIM YM, et al. Hepatopulmonary syndrome caused by hypothalamic obesity and nonalcoholic fatty liver disease after surgery for craniopharyngioma: a case report[J]. Ann Pediatr Endocrinol Metab, 2018, 23(1): 51-55. DOI: 10.6065/apem.2018.23.1.51. |
| [10] |
JONAS MM, KRAWCZUK LE, KIM HB, et al. Rapid recurrence of nonalcoholic fatty liver disease after transplantation in a child with hypopituitarism and hepatopulmonary syndrome[J]. Liver Transpl, 2005, 11(1): 108-110. DOI: 10.1002/lt.20332. |
| [11] |
JUSTINO H, SANDERS K, MCLIN VA. Rapid progression from hepatopulmonary syndrome to portopulmonary hypertension in an adolescent female with hypopituitarism[J]. J Pediatr Gastroenterol Nutr, 2010, 50(3): 334-336. DOI: 10.1097/MPG.0b013e3181a1c496. |
| [12] |
FUJIO A, KAWAGISHI N, ECHIZENYA T, et al. Long-term survival with growth hormone replacement after liver transplantation of pediatric nonalcoholic steatohepatitis complicating acquired hypopituitarism[J]. Tohoku J Exp Med, 2015, 235(1): 61-67. DOI: 10.1620/tjem.235.61. |
| [13] |
LIU SH, YANG XD, WANG YT. Hepatopulmonary syndrome complicated with hypophysis: a case report and literature review[J]. Chongqing Med, 2013, 42(1): 114-115. DOI: 10.3969/j.issn.1671-8348.2013.01.046. |
| [14] |
KHAN MJ, HUMAYUN KN, DONALDSON M, et al. Longitudinal changes in body mass index in children with craniopharyngioma[J]. Horm Res Paediatr, 2014, 82(6): 372-379. DOI: 10.1159/000368798. |
| [15] |
XIAO WS, LE YY, ZENG SL, et al. Research advances in the pathogenesis of nonalcoholic fatty liver disease[J]. J Clin Hepatol, 2020, 36(8): 1874-1879. DOI: 10.3969/j.issn.1001-5256.2020.08.043. |
| [16] |
WILLIAMS KW, ELMQUIST JK. From neuroanatomy to behavior: central integration of peripheral signals regulating feeding behavior[J]. Nat Neurosci, 2012, 15(10): 1350-1355. DOI: 10.1038/nn.3217. |
| [17] |
HILL JW, ELIAS CF, FUKUDA M, et al. Direct insulin and leptin action on pro-opiomelanocortin neurons is required for normal glucose homeostasis and fertility[J]. Cell Metab, 2010, 11(4): 286-297. DOI: 10.1016/j.cmet.2010.03.002. |
| [18] |
FUJⅡ H, KAWADA N, JSG-NAFLD JSGON. The role of insulin resistance and diabetes in nonalcoholic fatty liver disease[J]. Int J Mol Sci, 2020, 21(11): 4753-4761. DOI: 10.3390/ijms21113863. |
| [19] |
NISHIZAWA H, TAKAHASHI M, FUKUOKA H, et al. GH-independent IGF-I action is essential to prevent the development of nonalcoholic steatohepatitis in a GH-deficient rat model[J]. Biochem Biophys Res Commun, 2012, 423(2): 295-300. DOI: 10.1016/j.bbrc.2012.05.115. |
| [20] |
EVANS LM, DAVIES JS, ANDERSON RA, et al. The effect of GH replacement therapy on endothelial function and oxidative stress in adult growth hormone deficiency[J]. Eur J Endocrinol, 2000, 142(3): 254-262. DOI: 10.1530/eje.0.1420254. |
| [21] |
LU XL, JIANG YY, CAO Q. The role of oxidative stress and nuclear factor erythroid 2-related factor 2 in nonalcoholic fatty liver disease[J]. J Clin Hepatol, 2020, 36(4): 924-927. DOI: 10.3969/j.issn.1001-5256.2020.04.048. |
| [22] |
The Subspecialty Group of Endocrinologic, Hereditary and Metabolic Diseases, the Society of Pediatrics, Chinese Medical Association. Expert consensus on the diagnosis and management of growth hormone deficiency during the transition period[J]. China J Pediatr, 2020, 58(6): 455-460. DOI: 10.3760/cma.j.cn112140-20200314-00237. |
| [23] |
TAKANO S, KANZAKI S, SATO M, et al. Effect of growth hormone on fatty liver in panhypopituitarism[J]. Arch Dis Child, 1997, 76(6): 537-538. DOI: 10.1136/adc.76.6.537. |
| [24] |
GRILO-BENSUSAN I, PASCASIO-ACEVEDO JM. Hepatopulmonary syndrome: What we know and what we would like to know[J]. World J Gastroenterol, 2016, 22(25): 5728-5741. DOI: 10.3748/wjg.v22.i25.5728. |
DownLoad:
